Merit Medical Systems Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
16,570.00
22,974.00
23,802.00
20,121.00
27,523.00
42,017
Depreciation, Depletion & Amortization
32,542.00
35,929.00
37,425.00
43,755.00
53,582.00
69,546
Other Funds
550.00
260.00
6.00
365.00
61.00
8,862
Funds from Operations
60,770.00
66,812.00
66,730.00
66,625.00
86,926.00
122,477
Changes in Working Capital
9,397.00
13,487.00
2,728.00
13,026.00
24,199.00
35,944
Net Operating Cash Flow
51,373.00
53,325.00
69,458.00
53,599.00
62,727.00
86,533
Capital Expenditures
61,122.00
35,895.00
52,915.00
35,054.00
41,200.00
Sale of Fixed Assets & Businesses
113.00
98.00
1,247.00
19.00
21.00
Purchase/Sale of Investments
-
-
-
1,089.00
-
Net Investing Cash Flow
68,609.00
36,203.00
62,019.00
159,107.00
146,761.00
Issuance/Reduction of Debt, Net
10,489.00
25,374.00
16,897.00
115,459.00
46,416.00
Net Financing Cash Flow
14,768.00
16,968.00
10,235.00
121,095.00
96,517.00
Net Change in Cash
2,260.00
104.00
3,178.00
14,994.00
13,165.00
Free Cash Flow
8,132.00
19,144.00
18,499.00
20,762.00
24,104.00
Deferred Taxes & Investment Tax Credit
1,359.00
3,870.00
3,450.00
962.00
1,304.00
2,052
Net Assets from Acquisitions
31,600.00
5,927.00
12,368.00
125,161.00
105,582.00
Other Sources
24,000.00
5,521.00
2,017.00
-
-
Change in Capital Stock
3,729.00
8,146.00
6,668.00
5,271.00
142,994.00
Exchange Rate Effect
208.00
258.00
382.00
593.00
682.00

About Merit Medical Systems

View Profile
Address
1600 West Merit Parkway
South Jordan Utah 84095
United States
Employees -
Website http://www.merit.com
Updated 07/08/2019
Merit Medical Systems, Inc. engages in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. It operates through Cardiovascular and Endoscopy segment. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine and cardiovascular and critical care product groups.